Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Barbara Pro

90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease

scientific article

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

scientific article published on 25 September 2015

A phase 2 study of epothilone B analog BMS‐247550 (NSC 710428) in patients with relapsed aggressive non‐Hodgkin lymphomas ⬇️

scientific article published on January 10, 2013

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial

scientific article

A prospective cohort study of patients with peripheral T-cell lymphoma in the United States

scientific article

A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease

scientific article published on 23 December 2014

Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients

scientific article

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States

scientific article published on 10 January 2017

Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission

scientific article published on July 2015

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study

scientific article

Brentuximab vedotin in Hodgkin's lymphoma ⬇️

scientific article published on August 31, 2012

Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease

scientific article published on 31 January 2015

Current treatment of peripheral T-cell lymphoma

scientific article published on August 1, 2011

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

scientific article

Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature

scientific article published on August 2007

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine

scientific article

Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial

scientific article

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma

scientific article

Marginal zone lymphomas: factors that affect the final outcome

scientific article published on September 2010

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

scientific article

Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics

scientific article published on August 2007

New molecular targets for treatment of lymphoma

scientific article published in September 2004

Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

scientific article published on 08 July 2014

Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma

scientific article

Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial

scientific article

Peripheral T-Cell Lymphomas: A Review of Current Approaches and Hopes for the Future ⬇️

scientific article published on May 28, 2013

Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.

scientific article published on September 2006

Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma

scientific article

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

scientific article

Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma

scientific article

Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma

scientific article

Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms

scientific article

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma

scientific article

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

scientific article

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

scientific article

Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study

scientific article

Racial differences in chronic lymphocytic leukemia. Digging deeper

scientific article published on October 2013

Report of the 6th International Workshop on PET in lymphoma

scientific article published on 7 March 2017

Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting

scientific article published on 5 May 2016

Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma

scientific article published on 16 December 2016

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

scientific article

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

scientific article published on 10 March 2016

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

scientific article

Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials

scientific article published on 07 March 2017

Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.

scientific article published on 27 September 2006

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

scientific article

Targeting CD30 in Anaplastic Large Cell Lymphoma ⬇️

scientific article published on December 1, 2012

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium

scientific article

Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma

scientific article published on 26 May 2010

The lymphomas: molecular pathways and novel therapeutic targets

scientific article

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma

scientific article

Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy

scientific article

Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial

scientific article published on 29 December 2012

Paulina is supported by:

About Paulina

Help